Last reviewed · How we verify
VAC BNO 1095 film coated tablets — Competitive Intelligence Brief
phase 3
Herbal medicinal product
Immunology / Respiratory / Inflammation
Small molecule
Live · refreshed every 30 min
Target snapshot
VAC BNO 1095 film coated tablets (VAC BNO 1095 film coated tablets) — Bionorica SE. VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| VAC BNO 1095 film coated tablets TARGET | VAC BNO 1095 film coated tablets | Bionorica SE | phase 3 | Herbal medicinal product |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal medicinal product class)
- Bionorica SE · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- VAC BNO 1095 film coated tablets CI watch — RSS
- VAC BNO 1095 film coated tablets CI watch — Atom
- VAC BNO 1095 film coated tablets CI watch — JSON
- VAC BNO 1095 film coated tablets alone — RSS
- Whole Herbal medicinal product class — RSS
Cite this brief
Drug Landscape (2026). VAC BNO 1095 film coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/vac-bno-1095-film-coated-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab